FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matthew Cooperberg

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Anobel Y Odisho; Ardalan E Ahmad; Anna B Berry; Peter R Carroll; Matthew Cooperberg; Badrinath R Konety
Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology.
Matthew Cooperberg
Factors associated with treatment received by men diagnosed with prostate cancer in queensland, australia.
Matthew Cooperberg
Will biomarkers save prostate cancer screening?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matthew Cooperberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anobel Y Odisho; Ardalan E Ahmad; Anna B Berry; Peter R Carroll; Matthew Cooperberg; Badrinath R Konety
Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology.
European urology 2013;63(5):936-40.
2012: Matthew Cooperberg
Factors associated with treatment received by men diagnosed with prostate cancer in queensland, australia.
BJU international 2012;110(11 Pt B):E720.
2012: Matthew Cooperberg
Will biomarkers save prostate cancer screening?
European urology 2012;62(6):962-3; discussion 964-5.
2012: Marc A Dall'Era; Stephen J Freedland; Laurence H Klotz; Christopher Parker; Peter C Albertsen; Christopher Bangma; Peter R Carroll; H Ballentine Carter; Matthew Cooperberg; Mark S Soloway
Active surveillance for prostate cancer: a systematic review of the literature.
European urology 2012;62(6):976-83.
2012: Anobel Y Odisho; Ardalan E Ahmad; Anna B Berry; Peter R Carroll; Matthew Cooperberg; Badrinath R Konety
Reply to Jai Prakash, Apul Goel and Manish Garg's Letter to the Editor re: Anobel Y. Odisho, Anna B. Berry, Ardalan E. Ahmad, Matthew R. Cooperberg, Peter R. Carroll, Badrinath R. Konety. Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.019.
European urology 2012;62(5):e88.
2012: Allison S Glass; Matthew Cooperberg; Peter R Carroll
Early detection of prostate cancer: more information, more clarity.
European urology 2012;62(5):753-5; discussion 755-6.
2012: Sima P Porten; Matthew Cooperberg
High-risk nonmuscle invasive bladder cancer: definition and epidemiology.
Current opinion in urology 2012;22(5):385-9.
2012: Matthew Cooperberg; June M Chan
Editorial comment.
Urology 2012;80(2):305-6.
2012: Matthew Cooperberg
To predict the future, consider the present as well as the past.
European urology 2012;62(1):53-4.
2012: Matthew Cooperberg
Thwarting high-risk prostate cancer: the right treatments for the right patients.
European urology 2012;61(6):1107-9.
2012: G E Tasian; Peter R Carroll; Matthew Cooperberg; Janet E Cowan; Kirsten L Greene; M B Potter; J M Chan
PSA screening: determinants of primary-care physician practice patterns.
Prostate cancer and prostatic diseases 2012;15(2):189-94.
2012: Sanoj Punnen; Natalia Sadetsky; Matthew Cooperberg; Peter R Carroll
Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?
BJU international 2012;109(10):1520-4.
2012: Matthew Cooperberg
Adverse effects of androgen deprivation and the limits of national tumor registries.
European urology 2012;61(4):701-3; discussion 703-4.
2012: A K Wu; Matthew Cooperberg; A C Reese; Natalia Sadetsky; Katsuto Shinohara
Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer.
Prostate cancer and prostatic diseases 2012;15(1):100-5.
2012: Gregory E Tasian; Peter R Carroll; Matthew Cooperberg; Janet E Cowan; Nicholas A Daniels; Kirsten L Greene; Kian Keyashian; June M Chan
Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
Urologic oncology 2012;30(2):155-60.
2012: David S Aaronson; Peter R Carroll; Rosemary D Cress; R Adams Dudley; Nancy Hills; Anobel Y Odisho; Matthew Cooperberg
Proton beam therapy and treatment for localized prostate cancer: if you build it, they will come.
Archives of internal medicine 2012;172(3):280-3.
2012: Matthew Cooperberg; Anobel Y Odisho; Peter R Carroll
Outcomes for radical prostatectomy: is it the singer, the song, or both?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(5):476-8.
2011: Matthew Cooperberg
Words of wisdom. Re: Radical prostatectomy versus watchful waiting in early prostate cancer.
European urology 2011;60(4):868-9.
2011: Sanoj Punnen; Natalia Sadetsky; Matthew Cooperberg; Peter R Carroll
Androgen deprivation therapy and cardiovascular risk.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(26):3510-6.
2011: Matthew Cooperberg; Christopher J Kane; Katherine Mallin; Peter R Carroll
Treatment trends for stage I renal cell carcinoma.
The Journal of urology 2011;186(2):394-9.
2011: Sima P Porten; Katsuto Shinohara; Jared M Whitson; Matthew Cooperberg; Janet E Cowan; Kirsten L Greene; Maxwell V Meng; Nannette Perez; Peter R Carroll
Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(20):2795-800.
2011: Sima P Porten; Matthew Cooperberg; Badrinath R Konety; Peter R Carroll
The example of CaPSURE: lessons learned from a national disease registry.
World journal of urology 2011;29(3):265-71.
2011: Jared M Whitson; Sima P Porten; Joan F Hilton; Janet E Cowan; Nannette Perez; Matthew Cooperberg; Kirsten L Greene; Maxwell V Meng; Jeff Simko; Katsuto Shinohara; Peter R Carroll
The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer.
The Journal of urology 2011;185(5):1656-60.
2011: Adam C Reese; Natalia Sadetsky; Peter R Carroll; Matthew Cooperberg
Inaccuracies in assignment of clinical stage for localized prostate cancer.
Cancer 2011;117(2):283-9.
2011: Seth K Bechis; Peter R Carroll; Matthew Cooperberg
Impact of age at diagnosis on prostate cancer treatment and survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(2):235-41.
2011: Matthew Cooperberg; Janet E Cowan; Joan F Hilton; Adam C Reese; Harras B Zaid; Sima P Porten; Katsuto Shinohara; Maxwell V Meng; Kirsten L Greene; Peter R Carroll
Outcomes of active surveillance for men with intermediate-risk prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(2):228-34.
2010: Matthew Cooperberg; Andrew J Vickers; Jeanette M Broering; Peter R Carroll
Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.
Cancer 2010;116(22):5226-34.
2010: Jesse D Le; Matthew Cooperberg; Natalia Sadetsky; Adam B Hittelman; Maxwell V Meng; Janet E Cowan; David M Latini; Peter R Carroll
Changes in specific domains of sexual function and sexual bother after radical prostatectomy.
BJU international 2010;106(7):1022-9.
2010: Scott M Castle; Matthew Cooperberg; Natalia Sadetsky; Brian H Eisner; Marshall L Stoller
Adequacy of a single 24-hour urine collection for metabolic evaluation of recurrent nephrolithiasis.
The Journal of urology 2010;184(2):579-83.
2010: Adam C Reese; Matthew Cooperberg; Peter R Carroll
Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease.
The Journal of urology 2010;184(1):114-9.
2010: Anobel Y Odisho; Matthew Cooperberg; Vincent Fradet; Ardalan E Ahmad; Peter R Carroll
Urologist density and county-level urologic cancer mortality.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(15):2499-504.
2010: Michael L Eisenberg; Benjamin J Davies; Matthew Cooperberg; Janet E Cowan; Peter R Carroll
Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.
European urology 2010;57(4):622-9.
2010: Matthew Cooperberg; Jeanette M Broering; Peter R Carroll
Time trends and local variation in primary treatment of localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(7):1117-23.
2010: Sima P Porten; Matthew Cooperberg; Peter R Carroll
The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease.
BJU international 2010;105(4):472-5.
2010: Youngho Seo; Carina Mari Aparici; Matthew Cooperberg; Badrinath R Konety; Randall A Hawkins
In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(1):31-6.
2010: Matthew Cooperberg; Christopher J Kane; Janet E Cowan; Peter R Carroll
Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy.
BJU international 2010;105(1):88-92.
2009: Matthew Cooperberg; Shiro Hinotsu; Mikio Namiki; Kazuto Ito; Jeanette M Broering; Peter R Carroll; Hideyuki Akaza
Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4306-13.
2009: Matthew Cooperberg; Michael P Porter; Badrinath R Konety
Candidate quality of care indicators for localized bladder cancer.
Urologic oncology 2009;27(4):435-42.
2009: Matthew Cooperberg; John D Birkmeyer; Mark S Litwin
Defining high quality health care.
Urologic oncology 2009;27(4):411-6.
2009: Matthew Cooperberg; Jeanette M Broering; Peter R Carroll
Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.
Journal of the National Cancer Institute 2009;101(12):878-87.
2009: Matthew Cooperberg; Badrinath R Konety
Management of localized prostate cancer in men over 65 years.
Current opinion in urology 2009;19(3):309-14.
2009: Aaron D Berger; Wilfred Wu; Brian H Eisner; Matthew Cooperberg; Quan-Yang Duh; Marshall L Stoller
Patients with primary hyperparathyroidism--why do some form stones?
The Journal of urology 2009;181(5):2141-5.
2008: Alex K Wu; Matthew Cooperberg; Natalia Sadetsky; Peter R Carroll
Health related quality of life in patients treated with multimodal therapy for prostate cancer.
The Journal of urology 2008;180(6):2415-22; discussion 2422.
2008: Matthew Cooperberg
Prostate cancer risk assessment: choosing the sharpest tool in the shed.
Cancer 2008;113(11):3062-6.
2008: Christopher J Kane; Katherine Mallin; Jamie Ritchey; Matthew Cooperberg; Peter R Carroll
Renal cell cancer stage migration: analysis of the National Cancer Data Base.
Cancer 2008;113(1):78-83.
2008: Marc A Dall'Era; Badrinath R Konety; Janet E Cowan; Katsuto Shinohara; Frank Stauf; Matthew Cooperberg; Maxwell V Meng; Christopher J Kane; Nanette Perez; Viraj A Master; Peter R Carroll
Active surveillance for the management of prostate cancer in a contemporary cohort.
Cancer 2008;112(12):2664-70.
2008: Matthew Cooperberg; Katherine Mallin; Jamie Ritchey; Jacqueline D Villalta; Peter R Carroll; Christopher J Kane
Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004.
The Journal of urology 2008;179(6):2131-5.
2008: Matthew Cooperberg; Janet Cowan; Jeannette M Broering; Peter R Carroll
High-risk prostate cancer in the United States, 1990-2007.
World journal of urology 2008;26(3):211-8.
2008: Marc A Dall'Era; Matthew Cooperberg; June M Chan; Benjamin J Davies; Peter C Albertsen; Laurence H Klotz; Christopher A Warlick; Lars Holmberg; Donald E Bailey; Meredith E Wallace; Philip W Kantoff; Peter R Carroll
Active surveillance for early-stage prostate cancer: review of the current literature.
Cancer 2008;112(8):1650-9.
2007: Matthew Cooperberg; Quan-Yang Duh; G Bennett Stackhouse; Marshall L Stoller
Oral calcium supplementation associated with decreased likelihood of nephrolithiasis prior to surgery for hyperparathyroidism.
International journal of urology : official journal of the Japanese Urological Association 2007;14(12):1113-5.
2007: Matthew Cooperberg; Sanjukta Modak; Badrinath R Konety
Trends in regionalization of inpatient care for urological malignancies, 1988 to 2002.
The Journal of urology 2007;178(5):2103-8; discussion 2108.
2007: Matthew Cooperberg; Jack W McAninch; Nejd F Alsikafi; Sean P Elliott
Urethral reconstruction for traumatic posterior urethral disruption: outcomes of a 25-year experience.
The Journal of urology 2007;178(5):2006-10; discussion 2010.
2007: Jared M Whitson; Matthew Cooperberg; G Bennett Stackhouse; Marshall L Stoller
Urinary citrate levels do not correlate with urinary pH in patients with urinary stone formation.
Urology 2007;70(4):634-7.
2007: Matthew Cooperberg; Jeanette M Broering; Philip W Kantoff; Peter R Carroll
Contemporary trends in low risk prostate cancer: risk assessment and treatment.
The Journal of urology 2007;178(3 Pt 2):S14-9.
2006: Matthew Cooperberg; Stephen J Freedland; David J Pasta; Eric P Elkin; Joseph C Presti; Christopher L Amling; Martha Kennedy Terris; William J Aronson; Christopher J Kane; Peter R Carroll
Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy.
Cancer 2006;107(10):2384-91.
2006: David M Latini; Eric P Elkin; Matthew Cooperberg; Natalia Sadetsky; Janeen DuChane; Peter R Carroll
Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.
Cancer 2006;106(4):789-95.
2005: Matthew Cooperberg; Judd W Moul; Peter R Carroll
The changing face of prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(32):8146-51.
2005: William W Bassett; Matthew Cooperberg; Natalia Sadetsky; Stefanie Silva; Janeen DuChane; David J Pasta; June M Chan; Jason W Anast; Peter R Carroll; Christopher J Kane
Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
Urology 2005;66(5):1060-5.
2005: Kirsten L Greene; Janet E Cowan; Matthew Cooperberg; Maxwell V Meng; Janeen DuChane; Peter R Carroll
Who is the average patient presenting with prostate cancer?
Urology 2005;66(5 Suppl):76-82.
2005: Matthew Cooperberg; Thomas Chi; Amir Jad; Imok Cha; Paul Turek
Variability in testis biopsy interpretation: implications for male infertility care in the era of intracytoplasmic sperm injection.
Fertility and sterility 2005;84(3):672-7.
2005: Matthew Cooperberg; David J Pasta; Eric P Elkin; Mark S Litwin; David M Latini; Janeen Du Chane; Peter R Carroll
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.
The Journal of urology 2005;173(6):1938-42.
2005: Affonso H L A Camargo; Matthew Cooperberg; Brent D Ershoff; Jonathan N Rubenstein; Maxwell V Meng; Marshall L Stoller
Laparoscopic management of peripelvic renal cysts: University of California, San Francisco, experience and review of literature.
Urology 2005;65(5):882-7.
2005: Jason W Anast; Natalia Sadetsky; David J Pasta; William W Bassett; David M Latini; Janeen DuChane; June M Chan; Matthew Cooperberg; Peter R Carroll; Christopher J Kane
The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE).
The Journal of urology 2005;173(4):1132-8.
2005: Joseph A Mitchell; Matthew Cooperberg; Eric P Elkin; Deborah P Lubeck; Shilpa S Mehta; Christopher J Kane; Peter R Carroll
Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
The Journal of urology 2005;173(4):1126-31.
2005: Christopher J Kane; William W Bassett; Natalia Sadetsky; Stefanie Silva; Katrine Wallace; David J Pasta; Matthew Cooperberg; June M Chan; Peter R Carroll
Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.
The Journal of urology 2005;173(3):732-6.
2005: Matthew Cooperberg; Marshall L Stoller
Percutaneous neuromodulation.
The Urologic clinics of North America 2005;32(1):71-8, vii.
2004: Matthew Cooperberg; Sangtae Park; Peter R Carroll
Prostate cancer 2004: insights from national disease registries.
Oncology (Williston Park, N.Y.) 2004;18(10):1239-47; discussion 1248-50, 1256-8.
2004: Matthew Cooperberg; Deborah P Lubeck; Maxwell V Meng; Shilpa S Mehta; Peter R Carroll
The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2141-9.
2004: Matthew Cooperberg; Jeanette M Broering; David M Latini; Mark S Litwin; Katrine L Wallace; Peter R Carroll
Patterns of practice in the United States: insights from CaPSURE on prostate cancer management.
Current urology reports 2004;5(3):166-72.
2004: Kirsten L Greene; Maxwell V Meng; Eric P Elkin; Matthew Cooperberg; David J Pasta; Michael W Kattan; Katrine Wallace; Peter R Carroll
Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).
The Journal of urology 2004;171(6 Pt 1):2255-9.
2004: Matthew Cooperberg; Tracy M Downs; Peter R Carroll
Radical retropubic prostatectomy frustrated by prior laparoscopic mesh herniorrhaphy.
Surgery 2004;135(4):452-3; discussion 454.
2004: Matthew Cooperberg; Jeanette M Broering; Mark S Litwin; Deborah P Lubeck; Shilpa S Mehta; James M Henning; Peter R Carroll
The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
The Journal of urology 2004;171(4):1393-401.
2004: Bin Liu; Fraser Conrad; Matthew Cooperberg; Dmitri B Kirpotin; James D Marks
Mapping tumor epitope space by direct selection of single-chain Fv antibody libraries on prostate cancer cells.
Cancer research 2004;64(2):704-10.
2003: Matthew Cooperberg; E J Small; Anthony V D'Amico; P R Carroll
The evolving role of androgen deprivation therapy in the management of prostate cancer.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2003;55(4):219-38.
2003: Matthew Cooperberg; Deborah P Lubeck; Shilpa S Mehta; Peter R Carroll
Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).
The Journal of urology 2003;170(6 Pt 2):S21-5; discussion S26-7.
2003: Susan R Harlan; Matthew Cooperberg; Eric P Elkin; Deborah P Lubeck; Maxwell V Meng; Shilpa S Mehta; Peter R Carroll
Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
The Journal of urology 2003;170(5):1804-7.
2003: Matthew Cooperberg; Deborah P Lubeck; David F Penson; Shilpa S Mehta; Peter R Carroll; Christopher J Kane
Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.
The Journal of urology 2003;170(3):905-8.
2003: Matthew Cooperberg; Viraj A Master; Peter R Carroll
Health related quality of life significance of single pad urinary incontinence following radical prostatectomy.
The Journal of urology 2003;170(2 Pt 1):512-5.
2003: Matthew Cooperberg; Gary D Grossfeld; Deborah P Lubeck; Peter R Carroll
National practice patterns and time trends in androgen ablation for localized prostate cancer.
Journal of the National Cancer Institute 2003;95(13):981-9.
2003: Matthew Cooperberg; Theresa Koppie; Deborah P Lubeck; John Ye; Gary D Grossfeld; Shilpa S Mehta; Peter R Carroll
How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.
Urology 2003;61(1):190-6.
2002: Matthew Cooperberg; Deborah P Lubeck; Gary D Grossfeld; Shilpa S Mehta; Peter R Carroll
Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.
The Journal of urology 2002;168(2):491-5.
2001: Lee J. Goldstein; Ryan R Davies; John A Rizzo; J J Davila; Matthew Cooperberg; Richard K Shaw; Gary S Kopf; John A Elefteriades
Stroke in surgery of the thoracic aorta: incidence, impact, etiology, and prevention.
The Journal of thoracic and cardiovascular surgery 2001;122(5):935-45.
2001: Matthew Cooperberg; Paul N Fiedler
Ki-1 anaplastic large-cell lymphoma occurring at the site of ileocolonic anastomosis in a patient treated surgically for colonic adenocarcinoma: case report and review of the literature.
Annals of diagnostic pathology 2001;5(3):162-7.
2000: Matthew Cooperberg; Setsuko K Chambers; Thomas Rutherford; Harris E Foster
Cystic pelvic pathology presenting as falsely elevated post-void residual urine measured by portable ultrasound bladder scanning: report of 3 cases and review of the literature.
Urology 2000;55(4):590.
1998: F Garcia Sanchez; Giuseppe Pizzorno; SQ Fu; T Nanakorn; Diane S Krause; J Liang; E Adams; Janine J Leffert; L H Yin; Matthew Cooperberg; EG Hanania; W L Wang; J H Won; X Y Peng; Richard J Cote; R Brown; Barbara Burtness; R Giles; RG Crystal; Albert Deisseroth
Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
Blood 1998;92(2):672-82.